Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

By Papadopoulos Vasileios   Protopapas Andreas   Tsianos Epameinondas   Mimidis Konstantinos  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 8, 2009-08 ,pp. : 1021-1022

Informa Healthcare

Access to resources Recommend Favorite

Serum HBsAg quantification in treatment-naïve Indian patients with chronic hepatitis B

By Ramachandran Jeyamani   Ismail Ashrafali   Chawla Gaurav   Fletcher Gnanadurai   Goel Ashish   Eapen C.   Abraham Priya  

Indian Journal of Gastroenterology, Vol. 33, Iss. 2, 2014-03 ,pp. : 131-135

Springer Publishing Company

Access to resources Recommend Favorite

Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir

By de Niet A.   Takkenberg R.B.   Benayed R.   Riley-Gillis B.   Weegink C.J.   Zaaijer H.L.   Koot M.   Jansen P.L.M.   Beld M.G.H.M.   Lopatin U.   Reesink H.W.  

Scandinavian Journal of Gastroenterology, Vol. 47, Iss. 4, 2012-04 ,pp. : 475-481

Informa Healthcare

Access to resources Recommend Favorite

Serum HBV RNA and HBeAg are useful markers for the safe discontinuation of nucleotide analogue treatments in chronic hepatitis B patients

By Tsuge Masataka   Murakami Eisuke   Imamura Michio   Abe Hiromi   Miki Daiki   Hiraga Nobuhiko   Takahashi Shoichi   Ochi Hidenori   Nelson Hayes C.   Ginba Hiroyuki   Matsuyama Kazuhiro   Kawakami Hiroiku   Chayama Kazuaki  

Journal of Gastroenterology, Vol. 48, Iss. 10, 2013-10 ,pp. : 1188-1204

Springer Publishing Company

Access to resources Recommend Favorite

Transfusional transmitted virus seroprevalence in asymptomatic HBsAg (+) hepatitis B carriers

By Yenice N.   Gokden Y.   Erdem L.   Turkmen S.   Arican N.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 2, 2004-02 ,pp. : 174-177

Informa Healthcare

Access to resources Recommend Favorite